Good post? More like just the same old basher hammering your investment with old news, keeping the focus on past failures rather than the endpoint of the investment.

***************

``If the medEviewer becomes another fujitsu-10 ordeal``

The MedeViewer, imo, is a very different animal. In the Fujitsu case, they were the only customer for that product line and responsible for market penetration. When they decided to not move forward it was game-over...out of EDIG`s control. However, the medeViewer is EDIG`s product and targets multiple end users and is dependent on EDIG to find customers and create markets.

It is up to EDIG to sell it to gain revenues. They are not just a developer in this case, as they fill both roles. This is a much more lucrative business model.

I, as you, remain optimistic. as one product success can erase past disappointments. You only need to look at recent history to understand how a single product concept can turn a company around and yield healthy returns to its investors.